News | February 09, 2023
JB Pharma records revenue growth of 32% to Rs. 793 Cr in Q3 FY23
Profit after Tax stood at Rs. 106 crore as compared to Rs. 84 crore registering growth of 26%
Profit after Tax stood at Rs. 106 crore as compared to Rs. 84 crore registering growth of 26%
It will help upgrade the infrastructure and technologies of the country's biopharmaceuticals and in-vitro diagnostic industry
The top 15 Indian pharma players have continued to experience anaemic growth in the US market over the five years ended FY22
The company is one of the most profitable companies manufacturing speciality chemicals in India
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
The IPO is a complete OFS by existing shareholder Helix Investment Holdings
GMP-compliant documentation of all manufacturing steps for cell and gene therapies
Soluplus branded excipient play a critical role in enabling the drug development process for poorly soluble active pharmaceutical ingredients
TPE tubing is ideal for pharmaceutical bioprocessing applications because it can be welded to existing tubing lines, and heat-sealed to allow for easy, fast, and safe fluid transport in biopharma processes
South Asia’s largest exhibition for pharma brought together over 50,000 visitors from across the globe
Subscribe To Our Newsletter & Stay Updated
